Recruiting Asthma Studies in Boise
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT study (NCT06196879)....
Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma
The purpose of this study is to compare the efficacy and safety of albuterol/budesonide to albuterol in changes in airway inflammation, asthma symptoms, and rescue therapy utilization in adults with m...
About Asthma Clinical Trials in Boise
Asthma is a chronic respiratory condition where the airways become inflamed and narrow, causing difficulty breathing, wheezing, and coughing. It affects over 300 million people worldwide. Treatment includes inhaled corticosteroids, bronchodilators, and biologics for severe asthma.
There are currently 2 asthma clinical trials recruiting participants in Boise, ID. These studies are seeking a combined 536 participants. Research is being sponsored by Upstream Bio Inc., AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.
Asthma Clinical Trials in Boise — FAQ
Are there asthma clinical trials in Boise?
Yes, there are 2 asthma clinical trials currently recruiting in Boise, ID. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Boise?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boise research site will contact you about next steps.
Are clinical trials in Boise free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boise studies also compensate for your time and travel.
What asthma treatments are being tested?
The 2 active trials in Boise are testing new therapies including novel drugs, biologics, and treatment approaches for asthma.
Data updated March 2, 2026 from ClinicalTrials.gov